Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy Volunteers
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This research study is being conducted through the University of Pittsburgh Cancer Institute
(UPCI). It will evaluate the concentrations of Tasigna®, an oral drug used to treat some
types of cancer, in the blood of healthy volunteers when taken with and without Tums Ultra®,
a calcium product often used in the treatment of upset stomach and as a calcium supplement.